John La Rocca is SVP, General Counsel & Secry of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 0 shares of YMAB, which is worth approximately $0. The most recent transaction as insider was on Sep 16, 2025, when has been sold 21,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

John LaRocca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2025
SELL
Sale (or disposition) back to the issuer
-
21,500 Reduced 100.0%
0 Common Stock
Jan 17 2025
BUY
Grant, award, or other acquisition
-
21,500 Added 50.0%
21,500 Common Stock

Also insider at

AERI
AERIE PHARMACEUTICALS INC Healthcare
JL

John La Rocca

SVP, General Counsel & Secry
Durham, NC

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB